3 news items
Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update
ACXP
15 May 24
the European Society of Microbiology and Infectious Disease (or ESCMID) scientific congress held
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference
ACXP
2 May 24
with C. difficile Infection (CDI) were presented at the 34th Congress of ESCMID Global (European Society
Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference
ACXP
25 Apr 24
(CDI) will be presented at the 34th Congress of ESCMID Global (European Society of Clinical
- Prev
- 1
- Next